Flu drug, Xofluza, receives FDA approval

The U.S. Food and Drug Administration (FDA) today approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours. "This is the first new antiviral flu treatment with a novel mechanism of action approved by the ["]

The post Flu drug, Xofluza, receives FDA approval appeared first on Outbreak News Today.